Guyana vs Togo: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Guyana
25.4%
in 2021
Togo
25.4%
in 2021
Guyana rank
27th
Togo rank
27th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Guyana
- Togo
How they compare
Guyana currently reports 25.4% against 25.4% in Togo, a difference of 0.0%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Guyana ahead.
Guyana ranks 27th and Togo ranks 27th of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.1% | 28.3% | 2.8% | Guyana |
| 2010s | 28.6% | 27.2% | 1.5% | Guyana |
| 2020s | 27.5% | 25.9% | 1.6% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Guyana or Togo?
- Guyana, at 25.4% against 25.4% in Togo as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Guyana and Togo?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Togo?
- 22 years are reported by both, from 2000 to 2021.
- How do Guyana and Togo rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Guyana ranks 27th and Togo ranks 27th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).